Drug giants Pfizer, AstraZeneca in $100bn merger tussle (Update)
US drugs giant Pfizer wants a blockbuster merger with British rival AstraZeneca that will fuel cancer research, revealing on Monday that an informal approach worth almost $100 billion had been rejected.
Apr 28, 2014
0
0